Literature DB >> 25338077

Genetic predisposition for nonmedullary thyroid cancer.

Rebecca Nagy1, Matthew D Ringel.   

Abstract

Nonmedullary thyroid cancer (NMTC) can be sporadic or can occur as a component cancer as part of several well-described hereditary cancer syndromes. NMTC, particularly papillary thyroid cancer, also can occur by itself in families and is often termed familial NMTC or familial papillary thyroid cancer. The occurrence of NMTC in families, along with extensive population-based evidence from patients with sporadic thyroid cancer, together suggest that NMTC has a strong genetic component, only a small proportion of which has been characterized to date. Advances in genetic and genomic technology have rapidly advanced our understanding of the complex nature of NMTC susceptibility, although much remains to be explained. Herein, we describe the current state of knowledge, starting with a brief review of hereditary syndromic causes and moving on to describe recent data using modern genomic approaches to identifying genes involved in the predisposition to NMTC.

Entities:  

Mesh:

Year:  2014        PMID: 25338077     DOI: 10.1007/s12672-014-0205-y

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  70 in total

1.  The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.

Authors:  Meiko Takahashi; Vladimir A Saenko; Tatiana I Rogounovitch; Takahisa Kawaguchi; Valentina M Drozd; Hisako Takigawa-Imamura; Natallia M Akulevich; Chanavee Ratanajaraya; Norisato Mitsutake; Noboru Takamura; Larisa I Danilova; Maxim L Lushchik; Yuri E Demidchik; Simon Heath; Ryo Yamada; Mark Lathrop; Fumihiko Matsuda; Shunichi Yamashita
Journal:  Hum Mol Genet       Date:  2010-03-29       Impact factor: 6.150

2.  Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.

Authors:  Sandya Liyanarachchi; Anna Wojcicka; Wei Li; Malgorzata Czetwertynska; Elzbieta Stachlewska; Rebecca Nagy; Kevin Hoag; Bernard Wen; Rafal Ploski; Matthew D Ringel; Izabella Kozłowicz-Gudzinska; Wojciech Gierlikowski; Krystian Jazdzewski; Huiling He; Albert de la Chapelle
Journal:  Thyroid       Date:  2013-08-29       Impact factor: 6.568

3.  Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.

Authors:  Briseis Aschebrook-Kilfoy; Gila Neta; Alina V Brenner; Amy Hutchinson; Ruth M Pfeiffer; Erich M Sturgis; Li Xu; William Wheeler; Michele M Doody; Stephen J Chanock; Alice J Sigurdson
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

4.  Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.

Authors:  Qiang Zhang; Fangfang Song; Hong Zheng; Xiaoling Zhu; Fengju Song; Xiaofeng Yao; Lun Zhang; Kexin Chen
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

5.  Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.

Authors:  O Alsanea; N Wada; K Ain; M Wong; K Taylor; P H Ituarte; P A Treseler; H U Weier; N Freimer; A E Siperstein; Q Y Duh; H Takami; O H Clark
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

6.  A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.

Authors:  Huiling He; Rebecca Nagy; Sandya Liyanarachchi; Hong Jiao; Wei Li; Saul Suster; Juha Kere; Albert de la Chapelle
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.

Authors:  Christoph Reiners; Johannes Biko; Heribert Haenscheid; Helge Hebestreit; Stalina Kirinjuk; Oleg Baranowski; Robert J Marlowe; Ewgeni Demidchik; Valentina Drozd; Yuri Demidchik
Journal:  J Clin Endocrinol Metab       Date:  2013-04-24       Impact factor: 5.958

Review 8.  Diagnosis and management of differentiated thyroid cancer using molecular biology.

Authors:  Robert L Witt; Robert L Ferris; Edmund A Pribitkin; Steven I Sherman; David L Steward; Yuri E Nikiforov
Journal:  Laryngoscope       Date:  2013-02-12       Impact factor: 3.325

9.  Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms.

Authors:  Silvana M Giannelli; Laron McPhaul; Jon Nakamoto; Andrew G Gianoukakis
Journal:  Thyroid       Date:  2014-05-20       Impact factor: 6.568

10.  The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.

Authors:  Iñigo Landa; Sergio Ruiz-Llorente; Cristina Montero-Conde; Lucía Inglada-Pérez; Francesca Schiavi; Susanna Leskelä; Guillermo Pita; Roger Milne; Javier Maravall; Ignacio Ramos; Víctor Andía; Paloma Rodríguez-Poyo; Antonino Jara-Albarrán; Amparo Meoro; Cristina del Peso; Luis Arribas; Pedro Iglesias; Javier Caballero; Joaquín Serrano; Antonio Picó; Francisco Pomares; Gabriel Giménez; Pedro López-Mondéjar; Roberto Castello; Isabella Merante-Boschin; Maria-Rosa Pelizzo; Didac Mauricio; Giuseppe Opocher; Cristina Rodríguez-Antona; Anna González-Neira; Xavier Matías-Guiu; Pilar Santisteban; Mercedes Robledo
Journal:  PLoS Genet       Date:  2009-09-04       Impact factor: 5.917

View more
  11 in total

1.  HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Authors:  Tao Zhang; Mingzhao Xing
Journal:  J Natl Cancer Inst       Date:  2016-02-01       Impact factor: 13.506

2.  The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.

Authors:  Yanqiang Wang; Huiling He; Sandya Liyanarachchi; Luke K Genutis; Wei Li; Lianbo Yu; John E Phay; Rulong Shen; Pamela Brock; Albert de la Chapelle
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

3.  Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.

Authors:  Jingan Zhou; Preeti Singh; Kanhua Yin; Jin Wang; Yujia Bao; Menghua Wu; Kush Pathak; Sophia K McKinley; Danielle Braun; Carrie C Lubitz; Kevin S Hughes
Journal:  Ann Surg Oncol       Date:  2021-03-03       Impact factor: 5.344

4.  Hypermethylation of microRNA-497-3p contributes to progression of thyroid cancer through activation of PAK1/β-catenin.

Authors:  Yuxia Fan; Xin Fan; Hao Yan; Zheng Liu; Xiaoming Wang; Qingling Yuan; Jie Xie; Xiubo Lu; Yang Yang
Journal:  Cell Biol Toxicol       Date:  2022-01-23       Impact factor: 6.691

5.  The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Authors:  Artur Kowalik; Danuta Gąsior-Perczak; Martyna Gromek; Monika Siołek; Agnieszka Walczyk; Iwona Pałyga; Małgorzata Chłopek; Janusz Kopczyński; Ryszard Mężyk; Aldona Kowalska; Stanisław Góźdź
Journal:  Oncotarget       Date:  2017-04-06

6.  Genetic Association of XRCC1 Gene rs1799782, rs25487 and rs25489 Polymorphisms with Risk of Thyroid Cancer: a Systematic Review and Meta-Analysis

Authors:  Jamal Jafari Nedooshan; Mohammad Forat Yazdi; Hossein Neamatzadeh; Masoud Zare Shehneh; Saeed Kargar; Niloofar Seddighi
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

7.  HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Authors:  Maisa Pinheiro; Sandra Aparecida Drigo; Renata Tonhosolo; Sonia C S Andrade; Fabio Albuquerque Marchi; Igor Jurisica; Luiz Paulo Kowalski; Maria Isabel Achatz; Silvia Regina Rogatto
Journal:  Oncotarget       Date:  2017-06-20

Review 8.  Epigenetic modification and BRAF gene mutation in thyroid carcinoma.

Authors:  Guo Huang; Juan Chen; Jun Zhou; Shuai Xiao; Weihong Zeng; Jiliang Xia; Xi Zeng
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

9.  Thyroid and Breast Cancer in 2 Sisters With Monoallelic Mutations in the Ataxia Telangiectasia Mutated (ATM) Gene.

Authors:  Fabíola Y Miasaki; Kelly C Saito; Guilherme L Yamamoto; César L Boguszewski; Gisah A de Carvalho; Edna T Kimura; Peter A Kopp
Journal:  J Endocr Soc       Date:  2022-02-20

Review 10.  Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.

Authors:  Natalia Pstrąg; Katarzyna Ziemnicka; Hans Bluyssen; Joanna Wesoły
Journal:  Mol Cancer       Date:  2018-08-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.